Opportunity
Simpler Grants.gov #PAR-24-211
NHLBI K22 Career Transition Award for Postdoctoral Fellows (Clinical Trial Required)
Buyer
National Institutes of Health
Posted
July 15, 2024
Respond By
July 12, 2027
Identifier
PAR-24-211
NAICS
541715
This opportunity from the National Institutes of Health (NIH), specifically the National Heart, Lung, and Blood Institute (NHLBI), supports postdoctoral fellows transitioning to independent research careers: - Government Buyer: - National Institutes of Health (NIH) - National Heart, Lung, and Blood Institute (NHLBI) - OEMs and Vendors: - National Institutes of Health (NIH) is the primary federal entity; no commercial OEMs or vendors are specified - Products/Services Requested: - Career Transition Research Grant (K22 Clinical Trial Required) - Grant funding for postdoctoral fellows to move research from intramural (NIH) to extramural institutions - Focus on heart, lung, blood, and sleep disorders - Requires a clinical trial as part of the research plan - Two-phase support: up to 2 years mentored (intramural), 3 years independent (extramural) - Unique or Notable Requirements: - Applicants must propose a two-phase research plan - Transition to the extramural phase is contingent on successful progress review - Open to a wide range of eligible organizations, including nonprofits, businesses, government agencies, and educational institutions - No specific products, part numbers, or commercial equipment are being procured; this is a grant funding opportunity for research activities
Description
The NHLBI Career Transition Award (K22) program supports highly qualified postdoctoral fellows in the NHLBI Division of Intramural Research to transition their research programs to extramural institutions. The award provides two phases of research support: a mentored intramural phase lasting up to two years and an extramural phase lasting three years, totaling five years of support. Transition to the extramural phase requires approval based on the success of the mentored phase and an NHLBI progress review. The program aims to facilitate the development of new investigators in heart, lung, blood, and sleep disorders research.